Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Advaxis Secures a $30M Direct Placement Financing to Healthcare Specialist Investors
-
Hospitality Properties Trust (HPT) Prices 11M Share Stock Offering
-
Hospitality Properties Trust Prices Offering of 11,000,000 Common Shares
-
Amarin Corp plc (AMRN) Boosts Offering to 24.3M, Priced at $2.85/ADS
-
Amarin Announces Underwriters’ Exercise of Option to Purchase Additional American Depositary Shares
-
Arrowhead Pharmaceuticals Closes $45 Million Private Offering
-
Omeros (OMER) Prices $40M Common Stock Offering at $11.50/Share
-
Omeros Announces Pricing of Public Offering of Common Stock
-
Fed to raise rates this year, likely in Dec after election: Reuters poll
-
Amarin Corp plc (AMRN) Prices 21.1M Offering at $2.85/ADS
-
Amarin Prices Public Offering of American Depositary Shares
-
Orchid Island Capital Announces August 2016 Monthly Dividend and July 29, 2016 RMBS Portfolio Characteristics
-
Amarin Corp plc (AMRN) Announces Public ADS Offering
-
Amarin Announces Proposed Public Offering of American Depositary Shares
-
Cyclacel Pharmaceuticals Reports 2nd Quarter 2016 Financial Results
-
Omeros (OMER) to Offer $40M in Common Stock
-
Omeros Announces Public Offering of Common Stock
-
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
-
Arrowhead Research (ARWR) Prices $45M Private Stock Offering at $5.90/Share
-
Arrowhead Pharmaceuticals Prices $45 Million Private Offering
-
Fibrocell Announces Proposed Public Offering of Common Stock and Warrants
-
Celldex Reports Second Quarter 2016 Results
-
Vista Gold Corp. Completes Previously Announced US$17.3 Million Bought Deal Offering of Units
-
Cantor Fitzgerald Upgrades TrovaGene (TROV) to Buy
-
Aurinia Reports Second Quarter 2016 Financial Results and Operational Highlights
-
Cantor Fitzgerald Downgrades Shutterstock (SSTK) to Hold
-
Helix Financial Systems Adds Wedbush Securities as Client for its Repo Collateral Management Services
-
Strong U.S. employment report brightens economic outlook
-
Cantor Fitzgerald Downgrades The Rubicon Project, Inc. (RUBI) to Hold
-
Vista Gold Corp. Announces US$15 Million Bought Deal Offering of Units
-
Rocket Fuel (FUEL) Announces $50 ATM Offering
-
Rocket Fuel Registration Statement Including At-the-Market Equity Offering
-
Glaukos Corporation (GKOS) Raising PT After Blowing Out Numbers - Cantor Fitzgerald
-
LTC Properties (LTC) Enters $200M Equity Distribution Agreements
-
AngioDynamics (ANGO) Announces 2.25M Common Stock Secondary Offering
-
AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
-
Glaukos Corporation (GKOS): Cantor Expecting Upside In 2Q
-
FinTech Acquisition (FNTC) Shareholders Approve CardConnect Merger Agreement
-
FinTech Acquisition Corp. Shareholders Approve Definitive Merger Agreement with CardConnect
-
Cantor Fitzgerald Downgrades Equity Residential (EQR) to Hold
-
Orchid Island Capital Announces Second Quarter 2016 Results
-
Cantor Fitzgerald Downgrades Seattle Genetics (SGEN) to Hold
-
Rambler Metals & Mining PLC: Director / PDMR Shareholding - CORRECTION
-
Remarks as Prepared for Delivery by Lauren Manning
-
SPEECH EXCERPTS: Select Remarks from Tuesday Night's Program at the Democratic National Convention
-
Rick Miller and Randall Miles Join eXp World Holdings Board of Directors
-
Cantor Fitzgerald Downgrades Relypsa, Inc. (RLYP) to Hold
-
Gladstone Commercial Corporation Reports Results for the Second Quarter Ended June 30, 2016
-
Streetinsider.com's Hot Lunchtime Reads 7/25: (TRP) (WHR) (ALDR) (TBRA)
-
Tobira Therapeutics (TBRA) PT Cut to $19 at Cantor Fitzgerald; Keeps 'Buy'

